Letter from Patricia E. Hewitt, Lead Consultant in Transfusion Microbiology, to Dr. W. M. McClelland, re Management of potential donors known to have received blood from people subsequently shown to have developed variant CJD, flagging the individuals so no further blood is used, and mention of the development of a protocol for future cases